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Abstract
Objective
To characterize the impact of widespread inventory management policies on stock-outs of
essential drugs in Zambia’s health clinics and develop related recommendations.
Methods
Daily clinic storeroom stock levels of artemether-lumefantrine (AL) products in 2009–2010
were captured in 145 facilities through photography and manual transcription of paper
forms, then used to determine historical stock-out levels and estimate demand patterns.
Delivery lead-times and estimates of monthly facility accessibility were obtained through
worker surveys. A simulation model was constructed and validated for predictive accuracy
against historical stock-outs, then used to evaluate various changes potentially affecting
product availability.
Findings
While almost no stock-outs of AL products were observed during Q4 2009 consistent with
primary analysis, up to 30% of surveyed facilities stocked out of some AL product during Q1
2010 despite ample inventory being simultaneously available at the national warehouse.
Simulation experiments closely reproduced these results and linked them to the use of aver-
age past monthly issues and failure to capture lead-time variability in current inventory con-
trol policies. Several inventory policy enhancements currently recommended by USAID |
DELIVER were found to have limited impact on product availability.
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Conclusions
Inventory control policies widely recommended and used for distributing medicines in sub-
Saharan Africa directly account for a substantial fraction of stock-outs observed in common
situations involving demand seasonality and facility access interruptions. Developing cen-
tral capabilities in peripheral demand forecasting and inventory control is critical. More rigor-
ous independent peer-reviewed research on pharmaceutical supply chain management in
low-income countries is needed.
Introduction
Background
Stock-outs of essential medicines at the clinic level are an important and widely acknowledged
public health problem in sub-Saharan Africa (SSA) with a recognized negative impact on mor-
bidity, mortality and disease epidemiology [1,2]. Many possible causes have been cited, includ-
ing procurement financing and processes, supply capacity, communication and road
infrastructure, distribution resources and planning methods, personnel staffing and training,
coordination among stakeholders [3–5]. Reported related interventions include technical or
managerial training [6], visibility of stock levels with SMS messaging [7], re-organization of
distribution activities [8], supply-chain structure [9], and others. This study seeks to character-
ize the specific impact of inventory management policies currently used in many low-income
countries, leveraging the recent intervention in Zambia's public pharmaceutical supply chain
described by Vledder et al. and further discussed below (the 2009/10 pilot) [9].
Zambia's public pharmaceutical supply chain and the max-min inventory
policy
Most patients in Zambia receive medicines freely through the public health system. It involves
procurement of medicines with financing from the Government of Zambia and external
donor support, primary monthly distribution from a national warehouse in Lusaka to approx-
imately 70 district stores and 20 hospitals, and secondary monthly distribution from district
stores to approximately 1500 health clinics [10]. Availability of medicines in clinics is rela-
tively low and typical of SSA [11]. Stock accounting is performed by clinic staff who record
inventory transactions and historical storeroom stock levels for every product on a form often
called stock card (Fig 1A). Inventory management follows guidelines currently recommended
by the USAID|DELIVER project, which are also applied in many low-income countries [12].
They involve a periodic review base-stock policy [13] known as max-min inventory control,
and the monthly completion and upstream communication by every facility of request and
requisition forms (Fig 1B). Monthly replenishment quantities are determined as the difference
between a target (maximum stock level) and the sum of current on-hand and pipeline inven-
tory. That replenishment target is calculated as a multiple of average monthly issues over the
previous two to four months [12]. For products with demand seasonality such as anti-malar-
ials, USAID|DELIVER recently recommended other methods for calculating replenishment
targets [14,15].
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Fig 1. Main paper forms supporting inventory control system in Zambia. (A) Stock Control Card completed for every
product in each storage facility. (B) Request and Requisition Form transmitted upstream to calculate and communicate monthly
replenishment orders. Populating data shown for illustration purposes only. Only some of the pre-printed product descriptions
are shown.
doi:10.1371/journal.pone.0156026.g001
Inventory Management and Stock-Outs of Essential Drugs in Zambia
PLOS ONE | DOI:10.1371/journal.pone.0156026 May 26, 2016 3 / 18
The 2009/2010 supply chain pilot
The government of Zambia led from April 2009 to April 2010 a quasi-randomized field
experiment in 16 districts to evaluate two supply chain models (the 2009/10 pilot). Interven-
tion A maintained intermediary stock with picking and packing activities in district stores;
Intervention B converted district stores into cross-docking points for shipments pre-pack-
aged for the clinics at the national warehouse. For intervention A, maximum stock levels
were set to two months in clinics and three months in district stores. For intervention B, max-
imum stock levels in clinics were set to four months. In 12 intervention districts a new
employee (commodity planner) was solely dedicated to inventory management. In the
national warehouse, a team was dedicated to reviewing submitted replenishment requests.
This staff and process ensured a high adherence to the prescribed inventory control policies.
Specific procurement arrangements ensured high levels of stock availability at the central
warehouse during the pilot period for a sample set of products selected for evaluation. Pri-
mary analysis discussed in Vledder et al. focused on impact evaluation over Q4 2009. It
reports a substantial reduction of the average number of days without stock for these prod-
ucts in intervention B compared with intervention A and control facilities (Table a in S1 File
provides results for artemether-lumefantrine products). On this basis the government of
Zambia decided later in 2010 to progressively deploy district cross-docking to the entire
country [9].
Methods
Data collection
The four dosage forms (6, 12, 18 and 24 tablet strips) of artemether-lumefantrine (AL) were
selected because they involve representative distribution challenges (seasonality, distribution to
all clinics) and are important to public health. 975 photographs of their stock cards in 145 clin-
ics were taken by commodity planners during regular district tours between June 2009 and
June 2010. Database transcription was performed by a data entry firm using a double-key pro-
cess. Probability of stock-out was estimated for each product and day in this dataset as the frac-
tion of clinics with no inventory to the total number of clinics with available records.
All 17 clinics with time coverage of at least nine months in this dataset were selected from
five districts for demand estimation purposes. In each of these clinics, raw demand rate on any
day with at least one box in recorded inventory was calculated for every product. That quantity
was computed as the number of tablets in a box divided by the number of days between the last
and next issues of a box. To smooth discontinuities and estimate censored demand, a triple
centered moving average operator with successive half-widths 40, 30 and 20 days of non-cen-
sored data was applied [16]. Because of common demand substitution between AL products
(which contain identical pills), their individual demand estimates were summed across prod-
ucts and these sums were then averaged across clinics. This resulted in an estimate of average
daily demand for all AL products in a typical clinic. This total demand was split into demand
estimates for each product using proportions equal to the fractions of issues observed in the
stock card dataset.
To estimate demand distributions, several parametric probability distributions including
normal, Poisson, geometric, lognormal and negative binomial were fitted through maximum
likelihood to historical demand from the stock card dataset. Considering final likelihood and
parameter values of fitted distributions led to the selection of the lognormal distribution with a
coefficient of variation of 50% to represent weekly demand (see Section D in S1 File for more
details).
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Distribution from the national warehouse to clinics consist of a primary stage (national
warehouse to districts) and a secondary stage (districts to clinics). Primary distribution follows
a fixed and reliable monthly schedule, with a lead-time of approximately 2 weeks. Records of
secondary lead-times to 212 clinics were obtained from monthly reports submitted by com-
modity planners between May 2009 and June 2010. Staff in 212 clinics was surveyed for subjec-
tive estimates of the probability that in any week of each month a shipment ready for their
facility at the district could be delayed because of weather-related access problems. Secondary
lead-times without access problems were modeled as a geometric random variable with first
moment set to the sample mean estimated from historical data. Seasonal access problems were
captured by a Bernoulli random variable with time-dependent success probability given by the
surveyed subjective probability estimates.
Monthly closing stock levels of all AL products in the national warehouse between Novem-
ber 2007 and February 2011 were obtained from its stock management software. Between June
2009 and May 2010 the stock of all AL products available there for distribution was always
higher than 800,000 adult regimens equivalent, where 100 tablet strips of AL 6 (respectively AL
12, AL 18 and AL 24) = 25 (respectively 50, 75 and 100) adult regimens equivalent.
Simulation model
Our study relies on a discrete-event simulation model of the inventory of AL products in a typi-
cal clinic operated under max-min inventory control. This model was developed in the Java
programming language [17]. This methodology involves the computer representation of a
dynamic random system as a discrete sequence of events in time, and is common in research
focusing on inventory management [18]. In our case the main simulated variables of interest
are the inventory level of AL products in a typical clinic and the outstanding replenishment
orders sent by that clinic to an upstream facility (district or central warehouse). The relevant
events include replenishment orders, demand for products by patients, and deliveries. The
dynamics captured by the simulation model specify when these events occur on a simulated
timeline of weekly time increments, reflecting for example a random lead-time between order
and delivery. They also capture what happens to the inventory and outstanding replenishment
order variables when each of these events occurs, reflecting the specific calculation of replenish-
ment quantities as part of the max-min inventory control policy, or the random realizations of
demand. Consistent with relevant national warehouse stock records, our simulation model
assumes an infinite amount of inventory available upstream. Its initial simulation state has no
available inventory and no outstanding replenishment order. Subsequent simulation time steps
are one week and involve the following sequence:
1. Any replenishment order scheduled to be delivered that week is credited to the inventory
level;
2. If that week is the first of a calendar month (assumed monthly schedule for primary distri-
bution), an order quantity is calculated according to the min-max policy being simulated.
The future delivery week of that order is generated by adding a realization of the random
delivery lead-time described above to an assumed order transmission delay of two weeks;
3. Demand is generated as the realization of a lognormal random variable with time-depen-
dent mean estimated as discussed above and coefficient of variation equal to 50%. Stock
issues are calculated as the minimum of inventory level and demand, unmet demand as the
difference between demand and issues when positive, and the inventory level for the next
simulated week is calculated by subtracting issues.
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Each simulation replication in our study (that is each simulated history or path realization
of the inventory and order variables over time) involves a warm-up period of two years and a
data collection period of three years after that. This warm-up period is designed to eliminate
the impact of the arbitrary initial simulation state on the results. For each scenario consid-
ered, 100,000 simulation replications form the basis of reported statistical results. The simu-
lated performance measures include: service level, calculated as the fraction of demand
satisfied from available inventory over the total demand occurring during the data collection
period; and average and maximum inventory level over the data collection period. Simulated
inventory management policies are all variants of the max-min inventory policy using differ-
ent methods for calculating the replenishment target. These methods are characterized by
whether the target is calculated based on past average monthly issues (I) or average monthly
demand (D); the historical interval of time over which these averages are calculated (defined
in relation to the current month); and the multiple of these average monthly estimates used
to calculate the replenishment target. Our notation follows, for example 4 x I[-3,0] denotes a
replenishment target equal to four times average monthly issues calculated over the previous
three months, while 5 x D[-12,-9] denotes five times average monthly demand calculated
over the next three calendar months from the year before. We simulated the baseline policy
4 x I[-3,0] used during the 2009/10 pilot and evaluated the impact of its maximum stock mul-
tiple by also considering 3 x I[-3,0]; 5 x I[-3,0]; and 6 x I[-3,0]. We also considered the follow-
ing policy modifications recommended for malaria supply chains by the USAID|DELIVER
project [14]: 4 x I[-1,0]; 4 x I[-6,0]; 4 x I[-12,0]; 4 x I[-12,-9]. Finally, we assessed the
specific impact of past issues as opposed to demand information by simulating the policies
4 x D[-1,0]; 4 x D[-3,0]; 4 x D[-6,0]; 4 x D[-12,0]; and 4 x D[-12,-9]. We were not able to sim-
ulate the inventory replenishment policy based on seasonality indices that is described in the
recent concept paper by Watson et al., because its specifications assume perfect advance
knowledge of delivery lead-times and seasonal access restrictions [15].
Sensitivity analysis was performed with respect to demand seasonality by considering mean
demand curves obtained by vertically re-scaling the estimated baseline while keeping annual
average constant. We considered values from 1 to 34 for the resulting seasonality factor (ratio
of peak demand mean to average mean through the year). Sensitivity with respect to delivery
lead-times was also performed by considering values for the mean secondary lead-time distri-
bution ranging from 22 to 54 weeks.
Model validation
An important component of our simulation-based methodology is the validation of our
model out-of-sample, which was performed to evaluate its realism and predictive accuracy.
Specifically, actual field measurements of stock-outs were compared with their simulated val-
ues, which were obtained independently under model settings reproducing the conditions
believed to characterize the field data generation process. This required a modified experi-
mental design considering the four AL products separately because it was not clear how to
meaningfully aggregate their historical stock-out records. Specific initial conditions were also
used because the pilot set-up phase involved a large upfront delivery of inventory to partici-
pating health clinics before the implementation of policy 4 x I[-3,0]. Analysis of stock card
data reveals a variation of this initial delivery date across clinics between May 1 and Septem-
ber 30 2009. The quantity received then also varied across products and was estimated at 08,
18, 15 and 095 times the target stock level for product AL 6, 12, 18 and 24, respectively. To
capture these observations, validation experiments involved for each replication a starting
date of May 1 2008 with initial inventory equal to eight weeks of future demand, a simulation
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of the policy 2 x I[-3,0] until a date uniformly distributed between May 1 and September 30
2009, an initial pilot set-up order on that date for a quantity equal to 08, 18, 15 or 095
times the target stock level corresponding to the product considered, and a subsequent simu-
lation of monthly orders calculated according to the baseline pilot policy 4 x I[-3,0] until May
1 2010.
Results
Parameter estimation
Key statistics of the estimated demand model for all AL products include an annual average of
37 adult-equivalent regimens per week, with maximum and minimum averages of 57 and 26
adult-equivalent regimens per week in late February and late October, respectively (Fig 2). Esti-
mated proportions of demand for AL 6, 12, 18 and 24 were 048, 027, 030 and 052,
respectively.
Estimated mean secondary lead-time in periods without access interruptions was 4 weeks.
Average subjective probabilities provided for clinic accessibility were 078, 076, 078, 085,
093, 097, 097, 098, 099, 099, 095 and 085 for the months ranging from January to Decem-
ber, respectively. Key statistics of the resulting distribution lead-time model include an annual
average of 4 weeks, with maximum and minimum averages of 49 and 39 weeks in December
and July, respectively (Fig 3).
Fig 2. Estimated mean, 5th and 95th percentiles of combined weekly demand for all artemether-lumefantrine (AL) products at an average health
clinic. Statistics computed from stock card data of 17 clinics with at least nine months of consecutive demand data in stock card dataset, assuming no annual
trend.
doi:10.1371/journal.pone.0156026.g002
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Field stock-outs and model validation
The number of clinics for which historical stock data was obtained was similar across AL prod-
ucts, ranging from around 20 in March 2009 to around 80 in July 2009 (Fig 4). The variability
of this clinic sample size over time results from a number of factors that were difficult to con-
trol during the data collection campaign. These include field availability and functionality of
digital cameras (battery and memory card issues); schedule of clinic visits by commodity plan-
ners; understanding of, and adherence to, the data collection protocol; proper maintenance of
stock records by clinics over time; timeline of participation by commodity planners; etc.
The proportion of stocked-out clinics calculated from historical stock data consistently
decreased over the first two quarters of the 2009/10 pilot, from around 20% (30% for AL 6) in
May 2009 to 5% or less in October-November 2009 (Fig 5). After approximately two months at
this low level, this proportion increased again starting from January 2010 (December 2009 for
AL 24) however, peaking at approximately 20% (30% for AL 6) sometime in late February or
March 2010. Data available for April and May 2010 suggests that the fraction of stocked-out
clinics began to decrease again over this period.
Actual stock-out proportions for all AL products mostly lie between the 5th and 95th percen-
tiles of simulated stock-out proportions, with excesses above the 95th percentile (most notably
for AL 6 between July and October 2009) being of relatively small amplitude (Fig 5). Another
positive model validation follows from comparing the simulated number of days without stock
during Q4 2009 with the corresponding actual values estimated from the field measurements
organized independently for the evaluation of the 2009/10 pilot (see Section B in S1 File for
details).
Fig 3. Estimated mean, 5th and 95th percentiles of delivery lead-times between the central warehouse and an average health clinic. Estimates based
on record of lead-times to 212 clinics between May 2009 and June 2010 and surveys of subjective probabilities of shipment delays due to weather-related
access problems, assuming no annual trend.
doi:10.1371/journal.pone.0156026.g003
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Simulation experiments
Randomly selected simulation sample paths under policy 4 x I[-3,0] (Fig 6) explain the stock-
outs increase in Q1 and Q2 2010 seen in Fig 5: as demand starts to increase in December
(beginning of malaria season), the estimation of monthly issues then is based on the low histor-
ical demand of the three previous months so that the December shipment is small. While the
January and February shipments are substantially larger (because inventory has been depleted
at a faster rate during December), these are only received in April because of longer delivery
lead-times during the rainy season. Consequently the facility stocks out from February to early
April (peak demand period), but receives enough inventory to cover approximately five
months of demand in May, when the malaria season finishes and this quantity of medicines is
no longer needed.
Annual service level average of historical policy 4 x I[-3,0] over multiple replications and
under environmental conditions estimated from data is approximately 88% (Fig 7A and 7B),
with average and maximum yearly inventory levels of 2 and 43 months of demand, respec-
tively (Fig 7C–7F). Sensitivity analysis on the multiple of average past monthly issues used in
the replenishment target calculation shows a strong impact on both service level and inventory
levels. Specifically, increasing the target multiple from 4 months to 5 and 6 months increases
service levels from 88% to 95% and 97% (Fig 7A and 7B) and maximum inventory levels from
43 months to 6 and 78 months, respectively (Fig 7E and 7F). In addition, decreasing the target
multiple from 4 to 3 months reduces the average service level by more than 12 percentage
Fig 4. Number of health clinics for which artemether-lumefantrine (AL) products stock data was obtained from stock card collection process,
January 2009 –May 2010.
doi:10.1371/journal.pone.0156026.g004
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Fig 5. Actual and simulated stock-out probabilities for artemether-lumefantrine (AL) products, observed
through field stock cards (mean), and as predicted using simulationmodel (mean, 5th and 95th
percentiles). Actual stock-out probabilities estimated as the fraction of surveyed health facilities without stock.
Mean simulated stock-out probabilities estimated as the fraction of 100,000 replications without stock. Plotted 5th
and 95th percentiles correspond to a binomial distribution with success probability equal to the mean simulated
stock-out probability and number of trials equal to the clinic sample size shown in Fig 4.
doi:10.1371/journal.pone.0156026.g005
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points (Fig 7A and 7B), and decreases average and maximum inventory levels by approxi-
mately 50% (Fig 7C–7F). Increasing the delivery lead-time decreases both service level and
inventory levels, and increasing the demand seasonality factor decreases service level but tends
to increase inventory levels. In particular, an increase of the average delivery lead-time by only
one week reduces the service level of the historical policy 4 x I[-3,0] down to 83% (Fig 7A).
The changes in the calculation method for average monthly issues recommended by USAID
| DELIVER [14] have a limited impact on service level (reduction from 88% to 875% for 4 x I
[-6,0], increases to 89%, 90% and 92% for 4 x I[-12,-9], 4 x I[-12,0] and 4 x I[-1,0], respec-
tively–Fig 8A and 8B). All these recommended changes except 4 x I[-1,0] result in minor
decreases of average inventory, however policy 4 x I[-1,0] increases average inventory from 2
to 27 months (Fig 8C and 8D) and maximum inventory from 43 to 57 months (Fig 8E and
8F). Using past monthly demand in replenishment target calculations increases service level by
less than 2% for 4 x D[-1,0], 4 x D[-3,0] and 4 x D[-6,0], by 25% for 4 x D[-12,0] and by 5%
Fig 6. Randomly selected simulation sample path of historical max-min inventory control policy. Simulated data for policy 4 x I[-3,0] shown after
warm-up period of one hundred years chosen to eliminate impact of initial conditions. Demandmean data from Fig 2.
doi:10.1371/journal.pone.0156026.g006
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Fig 7. Simulated average service level, average andmaximum inventory levels whenmonthly replenishment targets are
calculated as different multiples of averagemonthly consumption. Each simulation replication includes a warm-up period of
two years and a data collection period of three years. Vertical whiskers around each data point show 95% confidence intervals
around mean simulation estimates, but are barely visible because they are calculated from 100,000 simulation replications.
Estimated baseline values are indicated with a vertical line.
doi:10.1371/journal.pone.0156026.g007
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Fig 8. Simulated average service level, average andmaximum inventory levels whenmonthly replenishment
targets are calculated with different methods for estimating historical averagemonthly consumption and
demand. Each simulation replication includes a warm-up period of two years and a data collection period of three
years. Vertical whiskers around each data point show 95% confidence intervals around mean simulation estimates,
but are barely visible because they are calculated from 100,000 simulation replications. Estimated baseline values are
indicated with a vertical line.
doi:10.1371/journal.pone.0156026.g008
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for 4 x D[-12,-9] (Fig 8A and 8B). The service level of all considered policies degrades as lead-
time increases, and in particular the best-performing policy 4 x D[-12,9] sees unmet demand
increase from 5% to 10% when average lead-time increases by only one week (Fig 8A). All poli-
cies except 4 x D[-12,9] and 4 x I[-12,0] see their service level decrease by approximately 25%
or more when demand seasonality increases from 22 to 3 (Fig 8B).
Discussion
Findings
This study reports clear evidence that substantial stock-outs of life-saving health products
occurred in Zambia’s public health facilities in the first quarter of 2010. This is noteworthy
because these products were available in the central warehouse at that time, and strict adher-
ence to a max-min inventory control policy used in many low-income countries was enforced.
These stock-outs can therefore be attributed to that inventory policy, as opposed to procure-
ment or training issues.
Our simple simulation model of this inventory policy offers relatively good predictive accu-
racy and closely reproduces key features of actual field stock-outs (Fig 5). Sensitivity analyses
reveal key drivers of these stock-outs: First, this policy ignores demand seasonality, even
though the need for malaria medicines and other health products may be driven by seasonal
events (e.g., flooding, changes in water quality, harvest-related exposures, etc. . .). Specifically,
its replenishment targets fail to anticipate upcoming predictable changes in demand (Fig 6).
Secondly, these targets also ignore predictable changes in delivery lead-times over time (due to
seasonal flooding) and across health facilities (due to local variations in transportation resource
availability). Finally, they rely on past consumption as opposed to demand data for predicting
future demand. This may create a negative self-perpetrating cycle whereby historical stock-
outs are ignored, resulting in insufficient replenishment quantities and increased likelihood
that more stock-outs will subsequently occur. In addition, these flaws also result in excessive
inventory costs. Specifically, seasonal demand increases are accounted for reactively and sea-
sonal lead-time increases are ignored, so that inventory covering multiple months of demand
occupies limited facility storage space after demand peaks. This is particularly wasteful because
stocks can be replenished on a monthly basis (Figs 6 and 7). Because of the predictable cyclical
nature of stock-outs and excessive inventory costs that are caused by max-min inventory con-
trol for life-saving medicines, this policy arguably constitutes a political liability.
The implementation of these inventory policies may nevertheless have been beneficial in
many resource-constrained environments in the past, because they facilitate adherence to
explicit and consistent management rules by different supply chain actors with limited time
and technical capabilities (Fig 1). They are relatively easy to understand and execute for facility
staff, and may thus be argued to promote ownership and transparency. Finally, medicines for
chronic conditions such as HIV anti-retrovirals have little demand seasonality, and tend to be
distributed in facilities with better delivery access. For these medicines, max-min inventory
policies are thus unlikely to generate the substantial and systematic stock-outs highlighted here
for anti-malarials. These policies are still likely to cause inefficient and excessive stock levels for
all products however, because they ignore differences in access conditions, both over time and
across facilities.
Our sensitivity analyses suggest that the potential to improve max-min inventory policies
through simple changes in parameter values or calculation methods is limited. While increas-
ing the multiple of average monthly issues determining the replenishment target does improve
service level, this also increases yearly average and maximum inventory levels by approximately
1:1 and 2:1 ratios, respectively (Fig 7). Even if this change were feasible at all given storage
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capacity constraints, it would thus be both costly and inefficient. Among the options recom-
mended by USAID | DELIVER for improving the inventory management of anti-malarials
[14], none reduces unsatisfied demand below 5% for average lead-times larger than or equal to
the baseline value estimated from field data (Fig 8A). Notably, all recommended methods
except one result in markedly lower service levels when demand seasonality increases, even
though this is the primary feature they are designed to address. One of these methods (using
past month of data only), by increasing the average maximum inventory level to approximately
six months of demand, would arguably do more harm than good (Fig 8E and 8F). Considering
the next three calendar months of the previous year would increase service level to about 95%
over a large range of demand seasonality scenarios (Fig 8A and 8B). This estimate may be opti-
mistic however because simulations results do not reflect potential demand estimation errors,
and 5% of unsatisfied demand for a life-saving drug under assumed conditions of infinite cen-
tral supply still seems cause for concern. That service level could also be substantially reduced
by any increasing trend in demand, due to its reliance on historical demand data almost one
year old.
Study strengths and limitations
The age of our dataset raises the question of whether the assumptions and conclusions of this
paper are still relevant. A first positive confirmation is that as of writing the exact same max-
min inventory replenishment policies considered in this paper are being used in Zambia’s pub-
lic health facilities, which was established by both field observations and an official statement
recently issued by the Managing Director of Zambia’s Medical Stores [19]. In addition, the spe-
cific inventory management policies considered here are currently being used or recommended
for use much beyond Zambia [12,14]. Confirmations that strong seasonality patterns still char-
acterize the demand for malaria products and that public pharmaceutical distribution still
involves long and variable lead-times in that country at present are also straightforward [19],
and these observations also seem to widely apply beyond Zambia. Finally, a key benefit of our
methodology involving both model validation and sensitivity analysis is precisely the ability to
establish the robustness of our findings in a wide variety of conditions beyond those observed
in 2009/2010 in Zambia. Indeed, our sensitivity analysis results shown in Figs 7 and 8 provide
insights applicable to drastically different demand environments, supply lead-time conditions
and inventory replenishment policies than are reflected by our original dataset. These observa-
tions all suggest that the key findings reported in this study remain applicable in Zambia and
the many other countries still using max-min inventory policies to manage the distribution of
their health products today.
Our field evaluation of stock-outs relies on stock control cards (Fig 1A) documenting inven-
tory located in the pharmacy but not in the clinical area of facilities. We believe resulting dis-
crepancies to be inconsequential because official facility management guidelines mandate that
health products be dispensed out of facility pharmacies in small quantities and only as needed.
Notably, current inventory control policies do not take clinical area stock into account (Fig 1B).
Finally, malaria products present a combination of challenges (demand seasonality, distri-
bution to remote facilities) that seem representative of many other essential medicines. Our
conclusions may not apply to all other health products however, in particular products with
cold chain requirements and very short shelf lives may deserve specific investigations.
Implications for supply chain practice and research
This study points to a contradiction of all max-min inventory management methods consid-
ered here, which are currently used for many health products throughout SSA: under a “pull”
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model [20] whereby facility/clinic staff compute replenishment quantities themselves, it is
debatable how much ownership is developed by merely executing imposed basic calculations.
Perceived system transparency due to simple and easy to understand inventory calculations is
also unclear, because order quantities can be subsequently rationed down due to central stock-
outs as part of a process that is not transparent. Finally, because these methods rigidly restrict
the input of health facilities to historical data, they do not even achieve the key potential benefit
of a decentralized distribution system, namely the acquisition of rich local information about
future supply and demand conditions. Because health facilities are often under-staffed [10], the
cost of local staff involvement in inventory calculations may thus outweigh its benefits. How-
ever, in a “push” model [20] whereby health facilities merely provide input data and replenish-
ment quantities are centrally determined (or the so-called “informed push” variant whereby a
private or internal operator focused on logistics regularly visits facilities to count stock and
issue replenishment quantities), potential constraints on technical capabilities of facility staff
become less relevant to inventory control. For such a model, the shipment calculation and fore-
casting methods studied here thus seem overly simplistic and their inventory/service level per-
formance unacceptable.
Our simulation study demonstrates that a root cause for the concerning stock-outs and inef-
ficient inventory levels observed is the underlying methodology used by the current max-min
policies considered for forecasting future demand. Indeed, this methodology is ad-hoc and fails
to properly capture the seasonality, trend and variations across facilities of both demand and
delivery lead-times. These problems have led other researchers to propose alternative forecast-
ing methodologies based on seasonality indices that are specific to demand for malaria com-
modities [15]. Given the higher conceptual complexity and computational requirements of
these methods however, it seems doubtful that they can be widely implemented in peripheral
facilities to improve inventory replenishment without substantial investments in computer
hardware, software and training. These investments may be disease-specific, and would need
to be complemented with methods and processes to also forecast delivery lead-times. Fortu-
nately however, several robust and scalable generic forecasting software implementing time-
series analysis methods are now available and widely used in private sector supply chains
because they enable distribution organizations to successfully address these exact forecasting
challenges across a wide range of different products [16]. While these solutions are relatively
user friendly, they do require a minimum level of appropriate quantitative training and a reli-
able computer system, so that in the short term their systematic use only seems practical at the
central warehouse level, or by a private third party logistics provider. As a result, a key opportu-
nity highlighted by our study is to implement tested industrial solutions and develop associated
basic capabilities for the forecasting of local demand and local delivery lead-times with season-
ality and trend at the central or perhaps regional level, and to modify current inventory replen-
ishment practices in order to leverage this forecasting capability.
Such an initiative would be synergistic with, but not dependent upon, the recent unprece-
dented increase in availability and affordability of wireless communications and portable com-
puting devices in SSA, which creates an historic, ground-breaking opportunity to improve
pharmaceutical supply chains and reduce stock-outs of medicines. Specifically, this develop-
ment conceptually enables the cost-effective digital recording and communication of all inven-
tory-related transactions using ergonomic portable devices (e.g., smartphones with barcode
scanner, tablets). This supply-chain digitization, pervasive in higher-income settings [21],
would (i) relieve overburdened health facility staff from time-consuming and inefficient paper-
work and stock counting activities, thus improving their productivity; (ii) create seamless visi-
bility of local inventory levels, demand patterns and delivery lead-times, thus transforming
critical yet currently problematic supply chain activities including performance management
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and procurement needs calculations; and (iii) facilitate the implementation of the forecasting
and inventory control methods described above, thus achieving higher service levels and lower
inventory costs.
While recent positive initiatives involving weekly stock reporting for anti-malarials using
SMS technology should be noted [9,22], these arguably fall short of the possible radical trans-
formation just described. This and specific results in this paper prompt an examination of the
processes by which innovations and technical recommendations for global health supply
chains are currently generated: in stark contrast with drug prescriptions and medical proce-
dures for individual patients, widespread guidelines for distributing inventory of health prod-
ucts affecting entire patient populations are currently designed and disseminated by publicly-
funded private firms without conflict of interest statements, without much reliance on inde-
pendent peer-reviewed research, and under insufficient technical oversight. We hope that this
work may help convey the need for independent peer-reviewed research on pharmaceutical
supply chains in low-income countries.
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